AUREKA LIMITED — AGM Information 2013

Sep 30, 2013

==> picture [168 x 118] intentionally omitted <==

NAVARRE MINERALS LIMITED

ABN 66 125 140 105

Notice of Annual General Meeting

The Annual General Meeting ( Meeting ) of Shareholders of Navarre Minerals Limited ( Navarre or the Company ) will be held on Friday 22 November 2013 at 11.00am AEDT at the offices of Herbert Geer Lawyers, Level 20, 385 Bourke Street, Melbourne, Victoria .

The Explanatory Statement that accompanies and forms part of this Notice describes the matters to be considered at the Meeting. Terms used in this Notice and the accompanying Explanatory Statement are defined in the glossary set out at the end of the Explanatory Statement.

ITEMS OF BUSINESS

Ordinary Business

Annual Accounts and Reports

To receive and consider the Directors’ Report, Financial Report and Auditor’s Report of Navarre for the financial year ended 30 June 2013.

Resolution 1 — Re-appointment of Mr Kevin Wilson as Director

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

That Mr Kevin Wilson, who retires by rotation in accordance with the Constitution and, being eligible, offers himself for election, be re-appointed as a Director.

Resolution 2 — Remuneration Report (non-binding resolution)

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

That the Remuneration Report set out in the Directors’ Report of the Company for the financial year ended 30 June 2013 be adopted.

Special Business

Resolution 3 — Approval of issue of 2013 Options to Mr Geoff McDermott

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

That for the purposes of Listing Rule 10.14 and for all other purposes, Shareholder approval is given for the issue of up to 600,000 Options to Mr Geoff McDermott, the Managing Director of the Company, under the Company’s Option Plan, at the exercise prices described in the Explanatory Statement and otherwise on the terms described in the Explanatory Statement.

1

N A V A R R E M I N E R A L S L I M I T E D

Resolution 4 — Approval of additional capacity to issue ordinary shares

To consider and, if thought fit, pass the following resolution as a special resolution:

That for the purposes of Listing Rule 7.1A and for all other purposes, Shareholder approval is given for the issue of ordinary shares by the Company pursuant to Listing Rule 7.1A, such that, subject to the conditions described in the Explanatory Statement, the Company will have the benefit of the additional capacity to issue ordinary shares as contemplated by Listing Rule 7.1A.

By order of the Board

Jane Nosworthy Company Secretary 1 October 2013

2

N A V A R R E M I N E R A L S L I M I T E D

Voting Entitlements

The Company has determined that for the purpose of voting at the Meeting, Shareholders eligible to vote at the Meeting are those persons who are the registered holders of Shares at 7.00pm (Melbourne time) on Wednesday 20 November 2013.

How to vote

Your vote is important. You may cast your vote in the following ways :

• by attending and voting at the Meeting on Friday 22 November 2013 at 11.00am AEDT; or

• by completing and returning the enclosed proxy form so that it is received by the Company’s share registry by 11.00am AEDT on Wednesday 20 November 2013; or

• in the case of a corporate shareholder, by appointing a corporate representative to attend the Meeting in person (using a certificate of appointment obtained from the Company’s share registry).

Voting in person

To vote in person, attend the Meeting on the date and at the place specified in the Notice. Shareholders are asked to arrive at the venue 30 minutes prior to the time designated for the Meeting so that the Company may check their shareholdings against the Company’s share register and note attendances.

Voting by proxy

To vote by proxy, the attached proxy form and the power of attorney or other authority (if any) under which it is signed must be provided to the Company’s share registry, Boardroom Pty Limited, in the enclosed Reply Paid envelope, or in any of the following ways:

• Online at www.boardroomlimited.com.au/vote/navarreagm2013

• By post to GPO Box 3993, Sydney NSW 2001, Australia

• By hand delivery to Level 7, 207 Kent Street, Sydney NSW 2000, Australia

• By fax on +61 2 9290 9655

Proxy forms must be received by the share registry no later than 11.00am AEDT on Wednesday 20 November 2013 (or, if the Meeting is adjourned, by no later than 48 hours before the commencement of the resumed meeting).

Proxies must be signed by the Shareholder or the Shareholder’s attorney. Proxies given by corporations must be signed by an attorney or executed by the corporation in accordance with the Corporations Act.

Voting through a corporate representative

A body corporate that is a Shareholder of the Company may appoint an individual to act as its representative at the Meeting in accordance with section 250D of the Corporations Act. The Company will require a certificate of appointment of the corporate representative, executed in accordance with the Corporations Act.

The certificate of appointment must be lodged with the Company’s share registry (see details above) before the Meeting or at the registration desk on the day of the Meeting. Please contact the Company or Boardroom Pty Limited on +61 1300 737 760 to obtain a certificate of appointment.

3

N A V A R R E M I N E R A L S L I M I T E D

Information about proxy voting

Please read this information carefully if you intend to appoint a proxy to attend the Meeting and vote on your behalf.

Appointment of proxies

A Shareholder entitled to attend and vote at the Meeting may appoint one or, if the Shareholder is entitled to cast two or more votes at the Meeting, two proxies to attend and vote on their behalf. Each proxy will have the right to vote on a poll and also to speak at the Meeting. A proxy need not be a member of the Company and can be either an individual or a body corporate.

Voting by proxies

The appointment of a proxy may specify the proportion or the number of votes that the proxy may exercise. Where two proxies are appointed and the appointment does not specify the proportion or number of the Shareholder’s votes each proxy may exercise, the votes will be divided equally among the proxies (ie. each proxy may exercise half the votes).

If a proxy is not directed how to vote on a resolution, the proxy may vote or abstain from voting on that resolution as they see fit.

Non-attendance by nominated proxy

If a proxy form is returned and no person or body corporate is named as the proxy or the nominated proxy does not attend the meeting, or does not vote on the resolution, the chair of the Meeting will act as proxy and vote in accordance with any instructions.

How the chair of the meeting will vote undirected proxies

The chair of the Meeting will vote undirected proxies in favour of each Resolution on which the chair is entitled to vote as proxy.

Proxy appointments in favour of any other Director or the Company Secretary that do not contain a direction on how to vote will be used where possible to support the resolutions proposed in the Notice.

Important information concerning proxy votes for Resolutions 2 and 3

The Corporations Act places certain restrictions on the ability of Key Management Personnel and their Closely Related Parties to vote on the advisory resolution to adopt the Company’s Remuneration Report and resolutions connected directly or indirectly with the remuneration of the Company’s Key Management Personnel.

For these reasons, Shareholders who intend to vote by proxy should carefully consider the identity of their proxy and are encouraged to direct their proxy as to how to vote on all Resolutions. If you do not do so, you risk your vote not being cast.

If you appoint the chair of the Meeting as your proxy but do not direct the chair how to vote in respect of either or both of Resolution 2 and Resolution 3, you are providing express authorisation for the chair of the Meeting to vote your proxy in relation to Resolution 2 and/or Resolution 3 (as applicable), notwithstanding that those resolutions are connected directly or indirectly with the remuneration of a member of the Company’s Key Management Personnel, which includes the Chairman .

As noted above, the chair of the Meeting intends to vote undirected proxies in favour of Resolutions 2 and 3. Accordingly, if you appoint the chair of the Meeting as your proxy (including an appointment by default) and you wish to vote differently to how the chair of the Meeting intends to vote on Resolution 2 and/or Resolution 3, you must mark ‘against’ or ‘abstain’ on the proxy form for the relevant Resolution.

4

N A V A R R E M I N E R A L S L I M I T E D

Voting Exclusions and Prohibitions

Resolution 2 – In accordance with the Corporations Act, a vote on Resolution 2 must not be cast (in any capacity) by or on behalf of:

• a member of Key Management Personnel whose details are included in the Remuneration Report; or

• a Closely Related Party of such a member.

However, a person described above may vote on Resolution 2 as proxy if the vote is not cast on behalf of a person described above and either:

• the person does so as a proxy appointed by writing that specifies the way the proxy is to vote on Resolution 2; or

• the person is the chair of the Meeting and the appointment:

• does not specify the way the proxy is to vote on Resolution 2; and

• expressly authorises the chair to exercise the proxy even if the resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel of the Company.

Resolution 3 – The Company will disregard any votes cast on these resolutions (in any capacity) by or on behalf of any Director (including Mr McDermott, Mr Wilson, Mr Naylor and Mr Dorward) and any of their associates. However, the Company need not disregard a vote if:

• it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or

• it is cast by the chair of the Meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

In accordance with the Corporations Act, a person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 3 if the proxy is either:

• a member of Key Management Personnel; or

• a Closely Related Party of such a member,

and the appointment does not specify the way the proxy is to vote on that particular resolution.

However, this prohibition does not apply if the proxy is the chair of the Meeting and the appointment expressly authorises the chair to exercise the proxy even if the resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel of the Company.

Resolution 4 - In accordance with Listing Rule 14.11.1, the Company is required to disregard any votes cast on Resolution 4 by a person or an associate of a person who may participate in the proposed issue of ordinary shares or who might obtain a benefit, except a benefit solely in the capacity of a holder of ordinary shares, if the resolution is passed. However, the Company need not disregard a vote if:

• it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or

• it is cast by the chair of the Meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

5

N A V A R R E M I N E R A L S L I M I T E D

At this stage, the proposed allottees of the ordinary shares are not known and identified. In accordance with the note to Listing Rule 14.11.1, a person’s vote will only be excluded from voting on Resolution 4 if there is more than a mere possibility that the person will participate in the proposed issue.

6

NAVARRE MINERALS LIMITED

ABN 66 125 140 105

Explanatory Statement

The purpose of this Explanatory Statement is to explain the resolutions in the accompanying Notice of Annual General Meeting and to provide Shareholders with all information known to the Company that is material to a decision on how to vote on those resolutions.

The Directors recommend Shareholders read the Notice and this Explanatory Statement in full before making any decision in relation to the Resolutions.

Capitalised terms in this Explanatory Statement are defined in the glossary at the end of this document.

Consider Accounts and Reports

The Corporations Act requires the Director’s Report, Financial Report and Auditor’s Report of the Company to be laid before the Meeting. Accordingly, the reports for the financial year ended 30 June 2013 will be presented for consideration by Shareholders. No resolution is required on these reports.

The chair of the Meeting will allow a reasonable opportunity for Shareholders to ask questions or make comments about those reports and the management of the Company. Shareholders will also be given a reasonable opportunity to ask the auditor questions about the conduct of the audit and the preparation and content of the Auditor’s Report.

Resolution 1 – Re-appointment of Mr Kevin Wilson as a Director

Mr Kevin Wilson retires by rotation in accordance with the Constitution and, being eligible for re-election, offers himself for re-appointment as a Director. Details of Mr Wilson’s qualifications and experience are set out in the Company’s 2012 Annual Report.

The Directors (other than Mr Wilson) recommend that Shareholders vote in favour of this resolution. Mr Wilson makes no recommendation.

Resolution 2 – Remuneration Report (non-binding resolution)

The Remuneration Report for the financial year ended 30 June 2013 is set out in the Company’s 2013 Annual Report. By way of summary, the Remuneration Report sets out the Company’s remuneration policies and sets out remuneration details for each Director and other Key Management Personnel of the Company.

Shareholders attending the Meeting will be given a reasonable opportunity to ask questions about, or make comments on, the Remuneration Report.

Under the Corporations Act, a listed entity is required to put to the vote a resolution that the Remuneration Report be adopted. The vote on this resolution is advisory only and does not bind the Directors or the Company. However, if at least 25% of the votes cast on Resolution 2 are cast against the adoption of the Remuneration Report at two consecutive annual general meetings, then a ‘board spill resolution’ must be put to the Shareholders proposing the calling of a Shareholder meeting to consider the appointment of Directors.

7

N A V A R R E M I N E R A L S L I M I T E D

If a board spill resolution is passed by the Shareholders, the Company is required to hold a further meeting of Shareholders within 90 days to consider replacing those Directors (other than the Managing Director of the Company) in office at the time the Remuneration Report was approved by the Board.

Less than 25% of votes cast at the last Annual General Meeting of the Company were cast against the resolution to adopt the Remuneration Report for the financial year ended 30 June 2012.

Resolution 3 – Issue of Options to Mr Geoff McDermott

Listing Rule 10.14 requires a listed company to obtain shareholder approval by ordinary resolution prior to the issue of securities to a director of the company under an employee incentive scheme. Accordingly, in accordance with Listing Rule 10.14, Shareholder approval is sought for the proposed grant of up to 600,000 Options to the Company’s Managing Director, Mr Geoff McDermott, under the Option Plan on the terms set out below.

The following table summarises the proposed Option grant to Mr McDermott:

Tranche	Number of Options	Test for grant	Exercise price	Expiry date
1	300,000	VWAP over the trading days during the calendar month of December 2013 is 15 cents or higher	15 cents	31/12/2017
2	300,000	VWAP over the trading days during the month of December 2013 is 20 cents or higher	20 cents	31/12/2017

If Shareholder approval is obtained, it is intended the Options will be issued in January 2014, but in any event no later than 12 months after the Meeting or any adjournment of that Meeting. The Options will only be issued if the Board (excluding Mr McDermott) determines that the applicable tests for grant of those Options have been satisfied. This will be considered by the Board (excluding Mr McDermott) in January 2014, based on a recommendation from the Remuneration & Nomination Committee (excluding Mr McDermott).

Details of the specific terms applicable to the proposed Option grant to Mr McDermott are set out below.

Test for grant

The Options are divided into two equal tranches of 300,000 Options.

The test for the grant of the Options is the volume weighted average price ( VWAP ) of shares in the Company over the trading days during the calendar month of December 2013 ( December 2013 VWAP ), as follows:

• tranche 1: 300,000 Options will be granted if the December 2013 VWAP is 15 cents or higher; and

• tranche 2: 300,000 Options will be granted if the December 2013 VWAP is 20 cents or higher.

Exercise price

The exercise price for tranche 1 will be 15 cents, and the exercise price for tranche 2 will be 20 cents. In the view of the Board (excluding Mr McDermott), these prices provide an appropriate hurdle to the exercise of the proposed Options, particularly in light of current economic circumstances, which continue to exert strong downward pressure on share prices in the small resource sector. The exercise prices of the proposed Options were set on 4 February 2013.

8

N A V A R R E M I N E R A L S L I M I T E D

Vesting

Each tranche of Options will vest in thirds, subject to the following vesting conditions, which must be satisfied or waived by the Company:

• one-third will vest when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after the date of grant of the Options;

• one-third will vest when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after 1 January 2015; and

• one-third will vest when the closing share price exceeds the exercise price of the Options for ten consecutive trading days after 1 January 2016.

Mr McDermott must also be employed as Managing Director of the Company at the time when the relevant vesting condition is satisfied or waived.

Upon vesting, the Options are exercisable at any time prior to the expiry date. However, if Mr McDermott ceases employment as Managing Director of the Company, any vested Options held by him may be exercised within a period of 90 days following the cessation of employment, and in any event no later than their expiry date, after which time they will lapse.

Expiry date

The expiry date of the Options will be 31 December 2017.

Additional information required by Listing Rule 10.15

• The maximum number of Options that may be issued to Mr McDermott if Resolution 3 is passed by Shareholders is 600,000.

• Mr McDermott is a Director.

• Each Option will be granted for nil consideration.

• No Options have been issued to Directors or other related parties since the last approval under the Listing Rules was obtained at the 2012 Annual General Meeting.

• All Directors are entitled to participate in the Option Plan.

• Voting exclusion statements apply to Resolution 3 as set out in the Notice.

• Mr McDermott will not receive a loan in relation to the exercise of the Options.

• If Shareholders do not approve the proposed grant of Options to Mr McDermott, the Company will need to consider other means of providing a long term incentive for the Managing Director, including providing a benefit to him in the form of cash.

The Board (other than Mr McDermott) unanimously recommends that Shareholders vote in favour of Resolution 3. Mr McDermott makes no recommendation.

Resolution 4 – Approval of additional capacity to issue ordinary shares

Listing Rule 7.1A entitles eligible entities to issue equity securities of up to 10% of the Company’s existing issued capital, subject to shareholder approval. In this regard, approval is sought from the Shareholders for the issue of Shares by the Company pursuant to Listing Rule 7.1A, such that the Company will have the benefit of the additional capacity to issue ordinary shares as contemplated by Listing Rule 7.1A.

9

N A V A R R E M I N E R A L S L I M I T E D

Resolution 4 is a special resolution and therefore must be approved by at least 75% of the total number of votes cast by Shareholders entitled to vote on the resolution (in person, by proxy, by attorney or, in the case of a body corporate, by a corporate representative).

An eligible entity for the purposes of Listing Rule 7.1A is an entity that, at the time of its annual general meeting, is not included in the S&P/ASX300 Index and has a market capitalisation of $300 million or less. The Company is an eligible entity.

If Resolution 4 is passed, the maximum number of Shares that the Company will be entitled to issue is the number calculated in accordance with the following formula (as set out in Listing Rule 7.1A.2):

(A x D) - E

where:

• A = the number of fully paid ordinary securities on issue 12 months before the date of issue or agreement,

• plus the number of fully paid ordinary securities issued in the 12 months under an exception in Listing Rule 7.2,

• plus the number of partly paid ordinary securities that became fully paid in the 12 months,

• plus the number of fully paid ordinary securities issued in the 12 months with the approval of Shareholders under Listing Rule 7.1 or Listing Rule 7.4,

• less the number of fully paid ordinary securities cancelled in the 12 months.

D = 10%

• E = the number of equity securities issued or agreed to be issued under Listing Rule 7.1A.2 in the 12 months before the date of issue or agreement to issue that are not issued with the approval of Shareholders under Listing Rule 7.1 or Listing Rule 7.4.

For example, on 31 August 2013, the Company had 59,622,973 Shares on issue. Assuming 1 million Shares are issued between 31 August 2013 and 31 August 2014 (ie. pursuant to options being exercised) then the Company will, as at 31 August 2014, be able to issue 6,062,297 Shares. This assumes a value of nil for variable “E” above.

The ability to issue ordinary shares under Listing Rule 7.1A is in addition to the Company’s ability to issue ordinary shares of up to 15% of its existing issued capital over a 12 month period without Shareholder approval permitted by Listing Rule 7.1.

Additional information required by Listing Rule 7.3A

The following information is provided in accordance with Listing Rule 7.3A with respect to Resolution 4:

• Minimum Price: The issue price of each Share will be no less than 75% of the VWAP over the 15 trading days on which trades in that class were recorded immediately before:

• the date on which the price at which the Shares are to be issued is agreed; or

• if the Shares are not issued within 5 trading days of the date on which the price is agreed, the date on which the Shares are issued.

10

N A V A R R E M I N E R A L S L I M I T E D

• Dilution: If Resolution 4 is passed, and the Company issues Shares pursuant to the approval under Listing Rule 7.1A, the existing Shareholders’ voting power in the Company will be diluted with examples of such dilution being set out in the table below. There is a risk that:

• the market price for the Company’s Shares may be significantly lower on the issue date than on the date of the approval under Listing Rule 7.1A; and

• the Shares may be issued at a price that is at a discount to the market price for those Shares on the issue date,

which may have an effect on the amount of funds raised by the issue of the Shares.

As required by Listing Rule 7.3A.2, the table below shows the potential dilution of existing Shareholders on the basis of three different assumed issue prices and values for the variable “A” calculated in accordance with the formula in Listing Rule 7.1A.2 (as set out above). The following assumptions are made in the table:

• the issue price is the closing price of the Company’s Shares on 26 September 2013;

• the number of Shares on issue is at 26 September 2013. This could increase as a result of the issue of Shares either with or without shareholder approval; and

• the maximum number of Shares are issued by the Company as are permitted under Resolution 4.

Variable “A” in Listing Rule 7.1A.2 (Number of Shares on issue)	50% decrease in issue price $0.021	50% decrease in issue price $0.021	Issue price $0.042	Issue price $0.042	100% increase in issue price $0.064	100% increase in issue price $0.064
	10% Voting Dilution	Capital Raised	10% Voting Dilution	Capital Raised	10% Voting Dilution	Capital Raised
59,622,973 Current)	5,962,297	$125,208	5,962,297	$250,416	5,962,297	$381,587
89,434,459 (50% increase in Current Variable A)	8,943,445	$187,812	8,943,445	$375,625	8,943,445	$572,380
119,245,946 (100% increase in Current Variable A)	11,924,594	$250,416	11,924,594	$500,833	11,924,594	$763,174

• Issue Date: Shareholder approval obtained under Listing Rule 7.1A is valid for a period commencing on the date of the Meeting and expiring on the first to occur of the following:

• the date that is 12 months after the date of the Meeting, being 22 November 2014; and

• the date of approval by the Shareholders of a transaction under Listing Rule 11.1.2 (significant change to the nature or scale of the Company’s activities) or Listing Rule 11.2 (disposal by the Company of its main undertaking).

• Purpose: The purpose for which Shares may be issued pursuant to the approval under Listing Rule 7.1A may be to raise funds for the Company and as non-cash consideration. Funds raised from the issue, if undertaken, would be used for exploration expenses, general working capital

11

N A V A R R E M I N E R A L S L I M I T E D

requirements and, potentially, the acquisition of new resources (including tenements and expenses associated with such acquisitions).

If the Company issues any Shares for non-cash consideration, the Company will release to the market a valuation of the non-cash consideration that demonstrates that the issue price of the Shares complies with Listing Rule 7.1A.3.

• Allocation Policy: The allottees may comprise existing Shareholders or new investors or a combination of both. The allottees will be determined by the Board, taking into account:

• alternative options for raising funds if applicable. For example, the Board will consider whether it is appropriate to raise required funds by way of an entitlement issue;

• the purpose of the issue;

• the impact of the issue on the control of the Company;

• market conditions and the financial position of the Company; and

• if applicable, advice from external advisors.

• The Company does not yet know the names of the allottees or, other than described above, the basis on which they will be identified or selected.

• The Company notes that:

• the Board has formed no specific intentions to offer any placement to any existing Shareholders, class of Shareholder or new investors;

• the Board will, prior to make any placement, consider whether the raising of funds could be achieved by means of an entitlement issue to existing Shareholders; and

• if any placement is announced, the Company would, in accordance with Listing Rule 3.10.5A, disclose its reasons for undertaking that particular issue as a placement, rather than an entitlements issue to existing Shareholders.

 The Company obtained Shareholder approval under Listing Rule 7.1A at its previous Annual General Meeting held on 30 November 2012. In accordance with Listing Rule 7.3A.6, the Company notes that in the 12 months preceding the date of this Meeting (being the 12 months to 22 November 2013), no Shares were issued by the Company. The only equity securities issued by the Company in the 12 months preceding the date of the Meeting are as follows, representing 5.72% of the total number of equity securities on issue at the commencement of that 12 month period:

• 1,846,693 Options issued to eligible shareholders who participated in the Company’s 2012 Share Purchase Plan, as disclosed to ASX on 12 December 2012. These Options are exercisable at $0.20 each on or before 31 December 2013. The full terms and conditions of the Options are contained in the Prospectus dated 2 November 2012 issued by the Company;

• 800,000 Options issued on 30 November 2012 to the Non-Executive Directors under the Company’s Option Plan, with shareholder approval, as disclosed to ASX on 3 December 2012. Each Non-Executive Director’s Options are divided into two equal tranches, with the first tranche exercisable at $0.30 each and the second tranche exercisable at $0.35 each, on or before 31 December 2015. The Options will vest when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after the relevant

12

N A V A R R E M I N E R A L S L I M I T E D

vesting date (31 December 2012 for the first tranche and 31 December 2013 for the second tranche);

• 500,000 Options issued on 30 November 2012 to the Managing Director under the Company’s Option Plan, with shareholder approval, as disclosed to ASX on 12 December 2012. These Options are exercisable at $0.25 each. Half the Options will vest when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after 30 November 2012. The remaining Options will vest in thirds, when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after the relevant vesting date (30 November 2012 for the first tranche, 1 January 2013 for the second tranche and 1 January 2014 for the third tranche). Half the Options will expire on 31 December 2013 and the other half will expire on 31 December 2015; and

• 400,000 Options issued to senior employees of the Company under the Company’s Option Plan, as disclosed to ASX on 14 March 2013. These Options are exercisable at $0.15 each on or before 31 December 2017. The Options will vest in thirds, when the Company’s closing share price exceeds the exercise price of the Options for ten consecutive trading days after the relevant vesting date (1 January 2014 for the first tranche, 1 January 2015 for the second tranche and 1 January 2016 for the third tranche).

• All the Options issued by the Company in the 12 months preceding the date of the Meeting were issued for nil consideration.

• A voting exclusion statement applies to Resolution 4, as set out in the Notice.

13

N A V A R R E M I N E R A L S L I M I T E D

Glossary

Annual Report

ASX

Board

the 2013 Annual Report ASX Limited (ACN 008 624 691) the board of Directors

Business Day a trading day on the financial market operated by ASX Company (or Navarre ) Navarre Minerals Limited (ACN 125 140 105) Constitution the constitution of the Company Corporations Act Corporations Act 2001 (Cth) Closely Related Party in respect of a member of Key Management Personnel, certain family members and dependants of the member and companies controlled by the member, as defined in section 9 of the Corporations Act

a director of the Company

Director a director of the Company Explanatory Statement this explanatory statement Key Management Personnel has the meaning given to that term in the accounting standards and broadly includes those persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly, including any Director (whether executive or otherwise)

Listing Rules the Listing Rules of ASX Meeting the Annual General Meeting of the Company to be held on 22 November 2013 at 11:00am (Melbourne time)

Non-Executive Directors the Company’s non-executive Directors, being Mr John Dorward, Mr Colin Naylor and Mr Kevin Wilson

Notice the Notice of Annual General Meeting accompanying this Explanatory Statement

Option an option issued to subscribe for a Share

Option Plan the Navarre Minerals Limited Option Plan

Remuneration Report contained in the Director’s Report section of the Annual Report Resolution a resolution contained in the Notice Share a fully paid ordinary share in the capital of the Company Shareholder (or member ) a registered member of the Company VWAP the volume weighted average price of the Company’s shares

14

==> picture [134 x 104] intentionally omitted <==

All Correspondence to:

 By Mail Boardroom Pty Limited GPO Box 3993 Sydney NSW 2001 Australia

Level 7, 207 Kent Street, Sydney NSW 2000 Australia  By Fax: +61 2 9290 9655  Online: www.boardroomlimited.com.au  By Phone: (within Australia) 1300 737 760 (outside Australia) +61 2 9290 9600

YOUR VOTE IS IMPORTANT

For your proxy vote to be effective it must be recorded before 11:00am AEDT on Wednesday, 20 November 2013.

 TO LODGE YOUR PROXY VOTE ONLINE

STEP 1: VISIT www.boardroomlimited.com.au/vote/navarreagm2013

STEP 2: Enter your holding/investment type: STEP 3: Enter your Reference Number: STEP 4: Enter your Voting Access Code:

PLEASE NOTE: For security reasons it is important you keep the above information confidential.

TO VOTE BY COMPLETING THE PROXY FORM

STEP 1 APPOINTMENT OF PROXY

Indicate who you want to appoint as your Proxy.

If you wish to appoint the Chairman of the Meeting as your proxy, mark the box. If you wish to appoint someone other than the Chairman of the Meeting as your proxy please write the full name of that individual or body corporate. If you leave this section blank, or your named proxy does not attend the meeting, the Chairman of the Meeting will be your proxy. A proxy need not be a security holder of the company. Do not write the name of the issuer company or the registered securityholder in the space.

Appointment of a Second Proxy

You are entitled to appoint up to two proxies to attend the meeting and vote. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by contacting the company’s securities registry or you may copy this form.

STEP 3 SIGN THE FORM

The form must be signed as follows:

Individual: This form is to be signed by the securityholder.

Joint Holding : where the holding is in more than one name, all the securityholders should sign.

Power of Attorney: to sign under a Power of Attorney, you must have already lodged it with the registry. Alternatively, attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: this form must be signed by a Director jointly with either another Director or a Company Secretary. Where the company has a Sole Director who is also the Sole Company Secretary, this form should be signed by that person. Please indicate the office held by signing in the appropriate place.

STEP 4 LODGEMENT

To appoint a second proxy you must:

(a) complete two Proxy Forms. On each Proxy Form state the percentage of your voting rights or the number of securities applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded.

(b) return both forms together in the same envelope.

Proxy which is a Body Corporate

Where a body corporate is appointed as your proxy, the representative of that body corporate attending the meeting must have provided an “Appointment of Corporate Representative” prior to admission. An Appointment of Corporate Representative form can be obtained from the company’s securities registry.

STEP 2 VOTING DIRECTIONS TO YOUR PROXY

To direct your proxy how to vote, mark one of the boxes opposite each item of business. All your securities will be voted in accordance with such a direction unless you indicate only a portion of securities are to be voted on any item by inserting the percentage or number that you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on a given item, your proxy may vote as he or she chooses. If you mark more than one box on an item for all your securities your vote on that item will be invalid.

Proxy forms (and any Power of Attorney under which a proxy form is signed) must be received no later than 48 hours before the commencement of the meeting, therefore by 11:00am AEDT on Wednesday, 20 November 2013. Any Proxy Form received after that time will not be valid for the scheduled meeting.

Proxy forms may be lodged using the enclosed Reply Paid Envelope or:

 Online www.boardroomlimited.com.au/vote/navarreagm2013

 By Fax + 61 2 9290 9655

 By Mail Boardroom Pty Limited GPO Box 3993, Sydney NSW 2001 Australia

• In Person Level 7, 207 Kent Street,

• Sydney NSW 2000 Australia

Attending the Meeting

If you wish to attend the meeting please bring this form with you to assist registration .

Navarre Minerals Limited

ABN 66 125 140 105

Your Address

This is your address as it appears on the company’s share register. If this is incorrect, please mark the box with an “X” and make the correction in the space to the left. Securityholders sponsored by a broker should advise their broker of any changes. Please note, you cannot change ownership of your securities using this form.

PROXY FORM

STEP 1

APPOINT A PROXY

I/We being a member/s of Navarre Minerals Limited and entitled to attend and vote hereby appoint

==> picture [23 x 20] intentionally omitted <==

Appoint the Chairman of the Meeting (mark box)

OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the full name of the person or body corporate (excluding the registered shareholder or the issuer company) you are appointing as your proxy below:

• PLEASE NOTE : Leave this box blank if you have selected the Chairman of the meeting. Do not insert your own name(s).

==> picture [350 x 20] intentionally omitted <==

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chairman of the Meeting as my/our proxy at the Annual General Meeting of the Company to be held at Herbert Geer Lawyers, Level 20, 385 Bourke Street, Melbourne on Friday, 22 November 2013 at 11:00am AEDT and at any adjournment of that meeting, to act generally on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, as the proxy sees fit).

Chairman authorised to exercise undirected proxies on remuneration related resolutions: If I/we have appointed the Chairman of the Meeting as my/our proxy or the Chairman of the Meeting becomes my/our proxy by default, I/we expressly authorise the Chairman of the Meeting to exercise my/our proxy in respect of Resolutions 2 and 3 (except where I/we have indicated a different voting intention below), even though Resolutions 2 and 3 are connected directly or indirectly with the remuneration of a member of key management personnel for Navarre Minerals Limited, including the Chairman.

Important Note: The Chairman of the Meeting will vote all undirected proxies in favour of all items of business (including Resolutions 2 and 3. If the Chairman of the Meeting is (or may become) your proxy, you can direct the Chairman to vote against, or to abstain from voting on, Resolution 2 or Resolution 3, by marking the 'Against' or 'Abstain' box opposite that resolution in step 2 below.

STEP 2

ITEMS OF BUSINESS

• If you mark the Abstain box for a particular item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your vote will not be counted in calculating the required majority if a poll is called.

ORDINARY RESOLUTIONS

For Against Abstain*

Resolution 1 Re-appointment of Mr Kevin Wilson as Director Resolution 2 Remuneration Report (non-binding resolution) Resolution 3 Approval of issue of Options to Mr Geoff McDermott SPECIAL RESOLUTION Resolution 4 Approval of additional capacity to issue ordinary shares

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 19] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 19] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 19] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

==> picture [23 x 20] intentionally omitted <==

STEP 3 SIGNATURE OF SHAREHOLDERS This form must be signed to enable your directions to be implemented.

Individual or Securityholder 1 Securityholder 2 Securityholder 3 Sole Director and Sole Company Secretary Director Director / Company Secretary Contact Name…………………………………………….... Contact Daytime Telephone………………………................................ Date / / 2013